Zheng Dong

Medical College of Georgia, USA

Dr. Dong has a long time interest in the research filed of cell injury and death under conditions of hypoxia, ischemia, and DNA damage agents. 1985-1989 B.Sc., Microbiology, Fudan University, China 1989-1994 Ph.D., Physiology, Shanghai Institute of Physiology, China 1994-1998 Post-doctoral fellow, University of Texas Health Science Center at San Antonio (UTHSCSA) 1998-1999 Instructor, UTHSCSA, TX 1999-2002 Assistant Professor, UTHSCSA, TX 2002-2007 Associate Professor 2007-present Professor, Director of Graduate Program, Medical College of Georgia, Augusta, GA. Research Career Scientist, Charlie Norwood VA Medical Center, Augusta, GA Selected Recent Publications (from 104): Jiang M et al. Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636-45, 2007. Brooks C et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with Mitofusins. Proc Natl Acad Sci (USA) 104: 11649-11654, 2007. Pabla N et al. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283(10): 6572 – 6583, 2008. Brooks C et al. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119(5): 1275-85, 2009. Jiang M et al. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 176(3):1181-92, 2010 Wei Q et al. Targeted deletion of Dicer from proximal tubules protects against ischemic acute kidney injury. JASN, 2010

Biography Updated on 19 April 2010

Scholarly Contributions [Data Provided by scopus]